Neurogene

NGNE • NASDAQ • Stock Fundamentals

Neurogene is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rachel L. McMinn, with a market cap of $428.2M.

Market Cap$428.2M

Employees91.0

CEORachel L. McMinn

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Neurogene

Neurogene (NGNE) has a market capitalization of $428.2M and trades on NASDAQ.

Neurogene has approximately 91 employees.